SLIDE 4 UNGASS 2016 on the World Drug Problem Outcome Document
We reiterate our commitment to promoting the health, welfare and well-being of all individuals, families, communities and society as a whole, and facilitating healthy lifestyles through effective, comprehensive, scientific evidence -based demand reduction initiatives at all levels, covering, …. early intervention, treatment, care, recovery, rehabilitation and social reintegration measures, as well as initiatives and measures aimed at minimizing the adverse public health and social consequences of drug abuse, and we recommend the following measures… (paragraphes (a) to (h).
(a) (a) Take effective pr primary pr prev. mea easures. s..
info
skills
to choose healthy life style
parenting
social env.
to educ. (b) (b) Take effective mea easures s to
the progressio n of drug use disorders through targeted early interventio ns for people at risk (c) (c) Inc ncrease the avai ailability, coverage & qua quality of
scie scientific evidence - base based pr prev. mea easures s and tools in multiple settings, reaching youth in school as well as out of school (d) (d) Promote the wel ell-being of society as a whole through the elaboration
scientific evidence- based prevention strategies centred on and tailored to the needs of individuals, families and communities (g) g) De Develop and and im improve rec ecreational al facil acilities and provide access for children and youth to regular sports and cultural activities, with a view to promoting healthy lives and lifestyles, (f (f) Consi sider en enhancing coo
between public health, education, la law en enforcement when developing prevention initiative
(e)
Involve, policymakers, parliam., educators, civil society, the scientific community, academia, target populations, individuals in recovery, private sector, in the development
programmes (h) (h) Promote and and im improve the systematic col
in information and and gathering
well as the sharing, at the national and international levels, of reliable and comparable data on drug use and epidemiology,